Want To Live Longer? Start Tracking This Specific Number

If you’re on a mission to live longer, experts say there’s one metric worth paying attention to. VO2 max – which sounds like ...

Dupixent® (dupilumab) Approved in Japan as the First Targeted Medicine to Treat Adults with Bullous Pemphigoid (BP)

Approval in moderate-to-severe patients was based on pivotal trial results showing over four times more Dupixent patients experienced sustained disease remission through Week 36 compared with placebo ...

Regeneron Pharmaceuticals, Inc.: Dupixent (dupilumab) Approved in Japan as the First Targeted Medicine to Treat Adults with Bullous Pemphigoid (BP)

Approval in moderate-to-severe patients was based on pivotal trial results showing over four times more Dupixent patients experienced sustained disease remission through Week 36 compared with placebo ...
Scientific Research Publishing

H-UQ-MFF: Hybrid Uncertainty-Aware Multi-Feature Fusion for Clinically-Translatable Glaucoma Detection with FDA-Compliant Validation ()

Although artificial intelligence (AI) has demonstrated potential in automating glaucoma screening, there is still a ...